Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion

Journal of Investigative Dermatology

Volumn 108, Issue 4, 1997, Pages 452-456

  Wraight, Christopher J ^a,c   Edmondson, Stephanie R ^a   Fortune, Denys W ^b   Varigos, George ^a   Werther, George A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b CytoPath   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

epidermis; hyper proliferation; keratinocytes

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY;

EID: 0030933171     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12289713     Document Type: Article

References (41)

1. Arkins S, Rebeiz N, Brunke-Reese D, Biragyn A, Kelley K: Interferon-γ inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol Endocrinol 9:350-360, 1995
2. Barker JNWN, Karabin GD, Stoof TJ, Sarma VJ, Dixit VM, Nickoloff BJ: Detection of interferon-γ mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 2:106-111, 1991
3. Barreca A, deLuca M, delMonte P, Bondanza S, Damonte G, Cariola G, diMarco E, Giordano G, Cancedda R, Minuto F: In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 151:262-268, 1992
4. Bata-Csorgo Z, Hammerberg C, Voorbees JL, Cooper KD: Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol 105:89S-94S, 1995
5. Batch JA, Mercuri FA, Edmondson SR, Werther GA: Localization of messenger ribonucleic acid for insulin-like growth factor binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 79:1444-1449, 1994
6. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA: Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 80:2282-2288, 1995
7. Bernerd F, Magnaldo T and Darmon M: Delated onset of epidermal differentation in psoriasis. J Invest Dermatol 98:902-910, 1992
8. Bjerke JR, Livden JK, Degré M, Matre R: Interferon in suction blister Huid from psoriatic lesions. Br J Dermatol 108:295-299, 1983
9. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger B, Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649, 1995
10. Edmondson SR, Werther GA, Russell A, LeRoith D, Roberts Jr CT, Beck F: Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: Relationship to insulin-like growth factor-I mRNA. Endocrinology 136:4602-4609, 1995
11. Elder JT, Fisher GJ, Lindquist PB, Bennet GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor-α in psoriatic epidermis. Science 243:811-814, 1998
12. Gillitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-I/II.-8 mRNA in situ. J Invest Dermatol 97:73-79, 1991
13. Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann A, Stingl G, Berger R: MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101:127-131, 1993
14. Grossman R, Krueger J, Yourish D, Granelli-Piperno A, Murphy D, May L, Kupper T, Sehgal P, Gottlieb A: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6371, 1989
15. Hertle M, Kubler M-D, Leigh I, Watt, F: Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 89:1892-1901, 1992
16. Higashiyama M, Hashimoto K, Matsumoto K, Yoshikawa K: Differential expression of transforming growth factor-α (TGF-α) and EGF receptor in transitional area of psoriatic epidermis. J Dermatol Sci 7:45-53, 1994
17. Hodak E, Gottlieb AB, Anzilotti M, Krueger JG: The insulin-like growth factor I receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: Correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 106:564-570, 1996
18. Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoku M, Miyazono K, Heldin CH, Funa-K: A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem 270:12373-12379, 1995
19. Krane J, Gottlieb A, Carter M, Krueger J: The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med 175:1081-1090, 1992
20. Krane JF, Murphy DP, Carter DM, Krueger JG: Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor 1/somatomedin C (IGF-I) on keratinocyte proliferation may be modulated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 96:419-424, 1991
21. Krueger JG, Krane JF, Carter DM, Gottlieb AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S-140S, 1990
22. Laporte M, Heenen M: The heterogeneity of the germinative compartment in human epidermis and its implications in pathogenesis. Dermatogy 189:340-343, 1994
23. Liu J-P, Baker J, Perkins A, Robertson E, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor-I (IGF-I) and type I IGF receptor (IGFIr). Cell 75:59-72, 1993
24. Neely EK, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG: Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol 96:104-110, 1991
25. Nickoloff BJ, Karabin GD, Barker JN, Griffiths CE, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138:129-140, 1991
26. Oh Y, Muller HL, Ng I, Rosenfeld RG: Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-J action. J Biol Chem 270:13589-13592, 1995
27. Potten CS: The epidermal proliferative unit: The possible role of the central basal cell. Cell Tissue Kinet 7:77-88, 1974
28. Rentrop M, Knapp B, Winter H, Schweitzer J: Aminosilane treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J 18:271-276, 1986
29. Ristow H-J, Messmer TO: Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 137:277-284, 1988
30. Ristow H-J: Effect of insulin-like growth factor-I/Somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium. Growth Regulation 3:129-137, 1993
31. Schmid P, Cox D, McMaster GK, Itin P: In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis. Arch Dermatol Res 285:334-340, 1993
32. Schmid P, Itin P, Cox D, McMaster GK, Horisberger MA: The type I interferon system is locally activated in psoriatic lesions. J Interferon Res 14:229-234, 1994
33. Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266, 1991
34. Takematsu H, Tagami, H: Granulocyte-macrophage colony-stimulating factor in psoriasis. Dermatologica 181:16-20, 1990
35. Tavakkol A, Elder J, Griffiths C, Cooper K, Talwar H, Fisher G, Kean K, Foltin S, Voorhees J: Expression of growth hormone receptor, insulin-like growth factor I (IGF-I) and IGF-I receptor mRNA and proteins in human skin. J Invest Dermatol 99:343-349, 1992
36. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705, 1993
37. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367, 1995
38. Van Erp PEJ, De Mare S, Rijzewijk JJ, Van de Kerkhof PCM, Bauer FW: A sequential double immunoenzymatic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem J 21:343-347, 1989
39. Weinstein GD, McCullough JE: Cell proliferation kinetics. In: Roenigk HH, Maibach HH (eds.). Psoriasis. Marcel Dekker, New York, 1990, pp 327-342
40. Wraight C, Murashita M, Russo V, Werther G: A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. J Invest Dermatol 103:627-631, 1994
41. Wraight CJ, Werther GA: Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line, HaCaT. J Invest Dermatol 105:602-607, 1995